Dare Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DARE and other ETFs, options, and stocks.

About DARE

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. 

CEO
Sabrina Martucci Johnson
CEOSabrina Martucci Johnson
Employees
24
Employees24
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2005
Founded2005
Employees
24
Employees24

DARE Key Statistics

Market cap
39.75M
Market cap39.75M
Price-Earnings ratio
-2.04
Price-Earnings ratio-2.04
Dividend yield
Dividend yield
Average volume
376.16K
Average volume376.16K
High today
$2.80
High today$2.80
Low today
$1.78
Low today$1.78
Open price
$1.81
Open price$1.81
Volume
3.23M
Volume3.23M
52 Week high
$9.19
52 Week high$9.19
52 Week low
$1.27
52 Week low$1.27

Stock Snapshot

With a market cap of 39.75M, Dare Bioscience(DARE) trades at $2.69. The stock has a price-to-earnings ratio of -2.04.

As of 2026-04-16, Dare Bioscience(DARE) stock has fluctuated between $1.78 and $2.80. The current price stands at $2.69, placing the stock +51.1% above today's low and -4.0% off the high.

The Dare Bioscience(DARE)'s current trading volume is 3.23M, compared to an average daily volume of 376.16K.

During the past year, Dare Bioscience(DARE) stock moved between $1.27 at its lowest and $9.19 at its peak.

During the past year, Dare Bioscience(DARE) stock moved between $1.27 at its lowest and $9.19 at its peak.

People also own

Based on the portfolios of people who own DARE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.